MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumoursAndrew R. Green, Emad A. Rakha|British Journal of Cancer|2016Cited by 125
MYC regulation of glutamine–proline regulatory axis is key in luminal B breast cancerMadeleine L. Craze, Andrew R. Green|British Journal of Cancer|2017Cited by 96
Biological and clinical significance of PARP1 protein expression in breast cancerAndrew R. Green, Emad A. Rakha|Breast Cancer Research and Treatment|2014Cited by 83
Lost in translation: preclinical studies on 3,4‐methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humansAndrew R. Green|British Journal of Pharmacology|2011Cited by 75
LitSumm: Large language models for literature summarisation of non-coding RNAsAndrew R. Green, Blake Sweeney, Anton I. Petrov et al.|arXiv (Cornell University)|2023Cited by 4